Revelation Biosciences In... (REVB)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
0.49
0.02 (4.10%)
At close: Jan 15, 2025, 1:18 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
PE Ratio | -28.48 | -0.33 | -8.4 | -56.08 | -24.41K |
PS Ratio | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.52 | 3.41 | -1.01K | 26.80 | -24.41K |
P/FCF Ratio | -0.47 | -0.32 | -8.97 | -425.12 | n/a |
P/OCF Ratio | -0.47 | -0.32 | -9.08 | -425.12 | n/a |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | -0.17 | n/a | n/a |
Quick Ratio | 2.18 | 1.22 | 0.89 | 3.82 | n/a |
Current Ratio | 2.18 | 1.22 | 0.89 | 3.82 | n/a |
Asset Turnover | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a |
Return on Equity (ROE) | -0.02 | -10.26 | 120.51 | -0.48 | 1.00 |
Return on Assets (ROA) | -0.01 | -1.96 | -5.87 | -0.35 | -0.16 |
Return on Capital (ROIC) | -1.3 | -10.32 | 120.14 | -0.04 | 1.00 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a |